Eric Blasius Risser - Feb 8, 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: Chief Operating Officer
Signature: /s/ Lynn M. Cilinski, Attorney-in-fact
Stock symbol: MGNX
Transactions as of: Feb 8, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/12/2024, 05:32 PM
Previous filing: Feb 17, 2023
Next filing: Feb 20, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Employee Stock Option (right to buy)	Award	$0	+90K		$0.00	90K	Feb 8, 2024	Common Stock	90K	$18.30	Direct	F1
transaction	MGNX	Restricted Stock Unit	Award	$0	+33.5K		$0.00	33.5K	Feb 8, 2024	Common Stock	33.5K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
F2	Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
F3	The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.